Characterization and in vitro evaluation of nimotuzumab conjugated with cisplatin-loaded liposomes. 2017

Héctor Vázquez-Becerra, and Enrique Pérez-Cárdenas, and Saé Muñiz-Hernández, and Vanessa Izquierdo-Sánchez, and Luis Alberto Medina
a Posgrado en Ciencias Químicas , Universidad Nacional Autónoma de México , Ciudad de México , México.

In this paper, we report the conjugation of the humanized monoclonal antibody nimotuzumab with cisplatin-loaded liposomes and the in vitro evaluation of its affinity for tumor cells. The conjugation procedure was performed through derivatization of nimotuzumab with N-succinimidyl S-acetylthioacetate (SATA) followed by a covalent attachment with maleimide groups at the end of PEG-DSPE chains located at the membrane of pre-formed liposomes. Confocal microscopy was performed to evaluate the immunoliposome affinity for EGFR antigens from human epidermoid carcinoma (A-431) and normal lung (MRC-5) cell lines. Results showed that the procedures implemented in this work do not affect the capability of the nimotuzumab-immunoliposomes to recognize the tumor cells, which overexpress the EGFR antigens.

UI MeSH Term Description Entries
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008301 Maleimides Derivatives of maleimide (the structural formula H2C2(CO)2NH) containing a pyrroledione ring where the hydrogen atom of the NH group is replaced with aliphatic or aromatic groups.
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D010714 Phosphatidylethanolamines Derivatives of phosphatidic acids in which the phosphoric acid is bound in ester linkage to an ethanolamine moiety. Complete hydrolysis yields 1 mole of glycerol, phosphoric acid and ethanolamine and 2 moles of fatty acids. Cephalin,Cephalins,Ethanolamine Phosphoglyceride,Ethanolamine Phosphoglycerides,Ethanolamineglycerophospholipids,Phosphoglyceride, Ethanolamine,Phosphoglycerides, Ethanolamine
D011092 Polyethylene Glycols Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS. Macrogols,Polyoxyethylenes,Carbowax,Macrogol,Polyethylene Glycol,Polyethylene Oxide,Polyethyleneoxide,Polyglycol,Glycol, Polyethylene,Glycols, Polyethylene,Oxide, Polyethylene,Oxides, Polyethylene,Polyethylene Oxides,Polyethyleneoxides,Polyglycols,Polyoxyethylene
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier

Related Publications

Héctor Vázquez-Becerra, and Enrique Pérez-Cárdenas, and Saé Muñiz-Hernández, and Vanessa Izquierdo-Sánchez, and Luis Alberto Medina
October 2010, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Héctor Vázquez-Becerra, and Enrique Pérez-Cárdenas, and Saé Muñiz-Hernández, and Vanessa Izquierdo-Sánchez, and Luis Alberto Medina
January 2020, International journal of nanomedicine,
Héctor Vázquez-Becerra, and Enrique Pérez-Cárdenas, and Saé Muñiz-Hernández, and Vanessa Izquierdo-Sánchez, and Luis Alberto Medina
September 2018, Molecules (Basel, Switzerland),
Héctor Vázquez-Becerra, and Enrique Pérez-Cárdenas, and Saé Muñiz-Hernández, and Vanessa Izquierdo-Sánchez, and Luis Alberto Medina
January 2019, Cogent biology,
Héctor Vázquez-Becerra, and Enrique Pérez-Cárdenas, and Saé Muñiz-Hernández, and Vanessa Izquierdo-Sánchez, and Luis Alberto Medina
April 2022, Drug development and industrial pharmacy,
Héctor Vázquez-Becerra, and Enrique Pérez-Cárdenas, and Saé Muñiz-Hernández, and Vanessa Izquierdo-Sánchez, and Luis Alberto Medina
July 2011, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences,
Héctor Vázquez-Becerra, and Enrique Pérez-Cárdenas, and Saé Muñiz-Hernández, and Vanessa Izquierdo-Sánchez, and Luis Alberto Medina
September 2010, Pharmaceutical research,
Héctor Vázquez-Becerra, and Enrique Pérez-Cárdenas, and Saé Muñiz-Hernández, and Vanessa Izquierdo-Sánchez, and Luis Alberto Medina
January 2024, ADMET & DMPK,
Héctor Vázquez-Becerra, and Enrique Pérez-Cárdenas, and Saé Muñiz-Hernández, and Vanessa Izquierdo-Sánchez, and Luis Alberto Medina
January 2007, Drug delivery,
Héctor Vázquez-Becerra, and Enrique Pérez-Cárdenas, and Saé Muñiz-Hernández, and Vanessa Izquierdo-Sánchez, and Luis Alberto Medina
August 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Copied contents to your clipboard!